EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, QUIA PHARMA AB's Enterprise Value is €0.26 Mil.
QUIA PHARMA AB's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2025 was €-0.66 Mil. Therefore, QUIA PHARMA AB's EV-to-FCF for today is -0.40.
The historical rank and industry rank for QUIA PHARMA AB's EV-to-FCF or its related term are showing as below:
FRA:99B0'
s EV-to-FCF Range Over the Past 10 Years
Min: -10.98 Med: -1.2 Max: 3.18
Current: -0.17
During the past 13 years, the highest EV-to-FCF of QUIA PHARMA AB was 3.18. The lowest was -10.98. And the median was -1.20.
FRA:99B0's EV-to-FCF is not ranked
in the Biotechnology industry.
Industry Median: 16.38
vs FRA:99B0: -0.17
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
QUIA PHARMA AB's PE Ratio (TTM) for today is calculated as:
QUIA PHARMA AB's share price for today is €0.0001.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. QUIA PHARMA AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 was €-0.001.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
QUIA PHARMA AB EV-to-FCF Related Terms
QUIA PHARMA AB EV-to-FCF Historical Data
* Premium members only.
The historical data trend for QUIA PHARMA AB's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:99B0 vs VRTX, REGN, ALNY: EV-to-FCF Comparison
For the Biotechnology subindustry, QUIA PHARMA AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QUIA PHARMA AB EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, QUIA PHARMA AB's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where QUIA PHARMA AB's EV-to-FCF falls into.
QUIA PHARMA AB's current Enterprise Value is €0.26 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. QUIA PHARMA AB's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2025 was €-0.66 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QUIA PHARMA AB (FRA:99B0) has a EV-to-FCF of -0.40 as of Jul. 07, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on QUIA PHARMA AB and its competitors.
Is QUIA PHARMA AB's EV-to-FCF too high?
QUIA PHARMA AB's current EV-to-FCF is -0.40.
How does QUIA PHARMA AB's EV-to-FCF compare to VRTX and REGN?
QUIA PHARMA AB's EV-to-FCF of -0.40 can be compared against companies in the Biotechnology industry. The industry median EV-to-FCF is 16.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 16.38, based on 329 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on QUIA PHARMA AB and its competitors. For the Biotechnology industry, the median EV-to-FCF is 16.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QUIA PHARMA AB's current EV-to-FCF is -0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QUIA PHARMA AB stock overvalued right now?
QUIA PHARMA AB (FRA:99B0) has a current EV-to-FCF of -0.40. The current EV-to-FCF is -0.40. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For QUIA PHARMA AB (FRA:99B0), the current EV-to-FCF is -0.40 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:99B0 has been successfully added to your 